FDA Guidance for Industry Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use

Titel:
FDA Guidance for Industry Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm080795.pdf

Dokumentenart:
Guidance for Industry
Inhalt:
FDA position bzgl der nötigen Daten zur Unterstützung der Lizensierung von kommerziellen Fibrinprodukten

Zurück

GMP Seminare nach Thema